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Echo solves clinical puzzle — cardiac amyloidosis case report
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Abstract
We present the case of a 53-year-old woman with New York Heart Association (NYHA) class III heart failure, despite 
optimal pharmacological therapy. Her medical history included: myocardial infarction with nonobstructive coronary ar-
teries (MINOCA), heart failure with reduced ejection fraction and quadrantanopia with sensory neuropathy diagnosed 
as ischaemic stroke. Transthoracic echocardiography showed significant left ventricular hypertrophy with a ‘granular’ 
myocardial texture, global systolic dysfunction and restrictive mitral filling pattern. Two-dimensional (2D) transthoracic 
echo strain analysis demonstrated decreased global longitudinal strain with apical sparing, and helped to fit all the 
pieces of the jigsaw together to reach a consistent clinical diagnosis of cardiac amyloidosis.
Key words: 2D transthoracic echocardiography, cardiac amyloidosis, speckle tracking echocardiography
Folia Cardiologica 2020; 15, 1: 61–63
Case report
A 53-year-old woman presented to the cardiology depart-
ment with shortness of breath, orthopnoea, palpitations 
and New York Heart Association (NYHA) class III heart fai-
lure of a few months’ duration, despite optimal pharmaco-
logical therapy with beta-blockers, angiotensin-converting 
enzyme inhibitors (ACEI), diuretics and digoxin. Three 
years earlier she had been hospitalised in our department 
due to exertional dyspnoea, slightly elevated troponins, 
and a reduced left ventricular ejection fraction (LVEF) of 
30%. Coronary angiography performed at the time did 
not reveal coronary artery disease. She was diagnosed 
with myocardial infarction with nonobstructive coronary 
arteries (MINOCA) and dilated cardiomyopathy (DCM). 
One and a half years before that she was also hospitali-
sed at a neurology department due to left superior qua-
drantanopia, dizziness, and numbness of the right upper 
extremity and right cheek. Computed tomography of the 
brain detected post-ischaemic injury, and she was treated 
conservatively for acute ischaemic stroke; all moderate 
symptoms persisted.
Physical examination on admission revealed regular 
pulse 65 bpm, normal blood pressure of 110/70 mm Hg, 
and moderate lower leg oedema. Her body mass index was 
21 kg/cm2. Six-minute walk test (6MWT) distance result was 
150 metres and N-terminal pro-B-type natriuretic peptide 
(NT-proBNP) level was 7474 pg/mL, normal troponin T and 
creatine kinase myocardial bound (CK-MB). Transthoracic 
echocardiography showed significant left ventricular hyper-
trophy (LVH) [left ventricle (LVMI) mass index 160 g/m2] with 
a ‘granular’ myocardial texture (Figure 1), global systolic 
dysfunction with left ventricular ejection fraction (LVEF) of 
30%, restrictive mitral filling pattern (E/A 2.6, E/E’ 20) with 
normal left atrial (LA) size [LA diameter 38 mm, left atrial 
volume index (LAVI) 32 mL/m2]. Right ventricular function 
was low [tricuspid annular plane systolic excursion (TAPSE) 
15 mm] with inferior vena cava diameter of 17 mm with-
out respiratory variation. Twelve-lead electrocardiography 
(ECG) showed sinus rhythm with low voltage in limb leads 
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subtypes involves a search for immune cell dyscrasia, 
myocardial scintigraphy with bone tracers, and cardiac 
biopsy. A diagnosis of AL type should prompt a haematology 
consult for specific treatment.
Our patient’s puzzling medical history featured seve-
ral significant elements. Firstly, the history of myocardial 
infarction with nonobstructive coronary arteries (MINO-
CA) — it is known that elevated troponin level may occur in 
amyloidosis [1]. Secondly — limb numbness, parasthesis 
and hypotension, recognised as ischaemic stroke, could re-
present misdiagnosed sensory and autonomic neuropathy, 
often occurring in patients with amyloidosis [2]; carpal tun-
nel syndrome and spinal canal stenosis are also common. 
Thirdly, heart failure can be a result of cardiac amyloidosis 
characterised by restrictive cardiomyopathy progressing 
to late-stage congestive heart failure with reduced ejec-
tion fraction [3]. Low voltage ECG with increased LV wall 
thickness, which is also typical for storage diseases, can 
be a whistleblower.
Classical features of amyloidosis in TTE include: symme-
tric LV and right ventricle (RV) thickening with normal to small 
cavity size, valvular thickening, granular myocardial texture, 
biatrial dilatation, pericardial effusion, progressive diastolic 
dysfunction and impairment of global longitudinal systolic 
(GLS) function with a relative ‘apical sparing’ pattern [3, 4].
and no features of ventricular hypertrophy, incomplete left 
bundle branch block (LBBB).
This surprising discrepancy between transthoracic 
echocardiography (TTE) and ECG generated a suspicion of 
amyloidosis. Two-dimensional speckle tracking echocar-
diography demonstrated severely decreased global longi-
tudinal strain —6.9% with less abnormal values of apical 
segments (apical sparing, the so-called ‘cherry on top’ pat-
tern). Cardiac magnetic resonance imaging showed sub-
endocardial circumferential late gadolinium enhancement, 
especially in basal segments of LV, as well as amyloid de-
position in both atria. Serum protein immunofixation-elec-
trophoresis detected a monoclonal band defined as immu-
noglobulin IgA-lambda.
Treatment was adjusted and a subcutaneous fat biop-
sy postponed at the patient’s request. After rapid clinical 
deterioration, she died at home a few days later.
Discussion
Amyloidosis results from extracellular deposition of insolu-
ble misfold fibrils. Cardiac involvement is observed in about 
50–60% of patients with systemic primary amyloidosis 
(AL, amyloid light chain) [1] and is also common in other 
variants (ATTR, amyloid transthyretine). Differentiating 
Figure 1A. Twelve-lead electrocardiography shows low voltage in limb leads; B, C. Apical four-chamber and three-chamber views (respecti-
vely) with increased left ventricular wall thickness and ‘granular’ texture of myocardium; D. Bull’s-eye map of longitudinal strain with apical 
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Due to the unexpected clinical course, we cannot prove 
our diagnosis with a histology specimen, but this case pre-
sents a set of diagnostic features typical for cardiac amylo-
idosis. Importantly, strain analysis by TTE helped to fit the 
pieces of the jigsaw together to form a consistent clinical 
diagnosis. The recognition of amyloidosis is increasingly 
Streszczenie
Przedstawiono opis przypadku 53-letniej kobiety z obniżoną tolerancją wysiłku fizycznego w III klasie czynnościowej 
według New York Heart Association (NYHA), mimo optymalnej farmakoterapii. W wywiadzie stwierdzono: przebyty 
zawał serca bez istotnych zmian w nasierdziowych tętnicach wieńcowych (MINOCA), niewydolność serca z obniżoną 
frakcją wyrzutową lewej komory oraz niedowidzenie kwadrantowe z neuropatią czuciową zdiagnozowane jako udar 
niedokrwienny mózgu. W echokardiograficznym badaniu przezklatkowym (TTE) uwidoczniono „ziarnistą” strukturę oraz 
znaczny przerost mięśnia sercowego lewej komory, uogólnioną dysfunkcję skurczową oraz restrykcyjny profil napływu 
mitralnego. Analiza dwuwymiarowa (2D) TTE wykazała zmniejszenie globalnego odkształcenia podłużnego z lepszą funk-
cją w obrębie koniuszka. Charakterystyczny obraz echokardiograficzny przyczynił się do złożenia wszystkich elementów 
klinicznych w diagnozę amyloidozy serca.
Słowa kluczowe: 2D echokardiografia przezklatkowa, amyloidoza serca, metoda śledzenia markerów akustycznych
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